Skip to main content
Equibles

HESTERBIO · Hester Biosciences Limited

Use HESTERBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HESTERBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,323.60 INR -8.50 (-0.36%) At close · Nov 13
Rebalance outlook locked
Market Cap
19.77B INR
Shares
8.51M
Volume · Nov 13 1744 Avg daily vol (3M) 5560

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close2,323.60 INR Open2,343.10 INR Day2,301.10–2,355.00 INR 52W close1,259.10–2,545.00 INR Avg vol 30d5K Last earningsNov 5, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Nov 5
Earnings call
Standalone Q2 PAT more than doubles as revenue rises 28%

Hester Biosciences reported standalone revenue growth of 28% in Q2 and PAT growth of 131%; consolidated revenue rose 38%, while H1 standalone revenue increased 21% and PAT 108%.

4 source passages
take you through Hester Biosciences performance for the second quarter and first half of financial year '27 standalone revenue increased by 28% in Q2 and 21% in H1 over the corresponding period of the previous year. PAT, which more than doubled, increasing by 131% during the quarter, and 108% in the first half. revenue grew by 38% in Q2 and 13% in H1, primarily driven by the India business. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▼5.6% 632.18M INR 116.62M INR '25 Q3 ▲3.4% 819.25M INR 12.91M INR '25 Q4 ▲2.2% 841.05M INR 164.42M INR '26 Q1 ▼15.2% 709.69M INR 144.49M INR '26 Q2 ▲22.5% 774.15M INR 87.65M INR '26 Q3 ▲22.2% 1.00B INR 159.82M INR '26 Q4 ▼8.2% 772.44M INR 969.81M INR '27 Q1 LATEST ▲38% 979.12M INR 203.64M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 1,259.10 INR Now 2,323.60 INR · 83% Range high 2,545.00 INR
vs 200-day avg +19% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:HESTERBIO -2.0% +5.8% +23.9% +1.5% +45.3%

Exchange listing

Market
XNSE
Ticker
HESTERBIO
ISIN
INE782E01017
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.hester.in/
Investor relations
https://www.hester.in/investor-relations

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-07-14 11.00 INR
2025-08-06 7.00 INR
2024-08-22 6.00 INR
2023-09-13 8.00 INR
2022-08-11 10.00 INR
2021-08-05 10.00 INR
2020-08-27 6.60 INR
2019-07-18 7.00 INR
2018-11-09 2.00 INR
2018-08-30 2.00 INR
2018-08-02 6.00 INR
2017-11-16 4.00 INR
2017-07-20 2.30 INR
2016-11-03 3.00 INR
2016-07-21 1.10 INR
2016-03-17 3.00 INR
2015-09-10 3.10 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-07-30 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-15 Transcript
    Hester Biosciences Limited Q4 & FY26 Earnings Conference Call
  • Earnings call · Q3 2026 2026-01-30 Transcript
    Hester Biosciences Limited Q3 and 9M FY26 Earnings Conference Call